Aerobic Exercise in Children With Moderate and Severe Asthma
Aerobic Exercise in Children With Moderate and Severe Asthma
Regular aerobic physical activity in short-term moderate asthma and severe:

 -  Reduce the levels of inflammatory mediators

 -  Improves functional capacity

 -  Improves Quality of Life

 -  Improved lung function

 -  Reduces the sensation of dyspnea

 -  Improves symptoms scores and medication use
Methods: Is designed a randomized clinical trial, efficacy, outpatient physical therapy
 developed in the Institute of Integrative Medicine Teacher Fernando Figueira (IMIP). A pilot
 study with 20 participants will be made initially to obtain a sample calculation.
 Subjectively estimated it will take about 50 participants, with possible losses. Will include
 children older than eight years, diagnosis of moderate and severe persistent asthma according
 to criteria of Global Initiative National Asthma (GINA) and forced expiratory volume in one
 minute (FEV1) below 80% predicted. Will be excluded from the study associated with disease
 that limits physical activity, such as neuromuscular diseases, congenital or acquired heart
 disease, chronic lung disease associated exacerbation of the crisis and significant cognitive
 deficit, which makes the participant to respond adequately to the questionnaire and / or
 inability to meet the commands. Eligible patients will be randomized into two groups: control
 group, which is not subjected to any kind of exercise and the intervention group, which will
 be submitted to aerobic exercise for 30 minutes three times a week for six weeks. The two
 groups will be evaluated before and at the end of six weeks by testing for 6-minute walk,
 analysis of dyspnea, questionnaire of quality of life, pulmonary function test (FEV1, FVC),
 inflammatory markers (cytokine ).
Inclusion Criteria:

 -  Age greater than eight and less than nineteen years

 -  Diagnosis of moderate to severe persistent asthma according to criteria of GINA

 -  forced expiratory volume in one minute (FEV1) below 80% of predicts

 -  Initiation of treatment with inhaled corticosteroids for at least eight weeks before
 the start of collection.

 Exclusion Criteria:

 -  associated disease that limits physical activity, such as neuromuscular disease,
 congenital or acquired, severe cor pulmonate, severe congenital malformation

 -  associated with chronic lung disease (cystic fibrosis, bronchiectasis,
 bronchopulmonary dysplasia, interstitial lung diseases

 -  significant cognitive deficit, which makes the participant to respond adequately to
 the questionnaire and / or failure to meet the commands

 -  exacerbation of crisis (This will be a temporary exclusion criterion, as having taken
 action as directed by medical routine, the participant can return to training)

 -  mental deficit.